ArticleCureus2026
Synchronous Intra-ampullary Papillary-Tubular Neoplasm and Gallbladder Cancer.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Intra-ampullary papillary-tubular neoplasms (IAPNs) are rare precursor lesions of the ampulla of Vater, with a high propensity for progression to invasive carcinoma. Synchronous primary malignancies of the biliary tract are uncommon, and their occurrence in the absence of congenital anomalies such as pancreaticobiliary maljunction (PBM) has not been well documented. We report a case of an IAPN coexisting with a synchronous gallbladder carcinoma in a patient without identifiable predisposing anomalies. A 70-year-old woman with a history of interstitial pneumonia, acute pancreatitis, and mixed connective tissue disease on chronic steroids was under surveillance for branch-duct intraductal papillary mucinous neoplasm of the pancreatic body. Follow-up contrast-enhanced computed tomography revealed a 14-mm enhancing mass at the ampulla of Vater, with upstream dilation of both the pancreatic and bile ducts. Endoscopic evaluation and biopsy confirmed adenocarcinoma, and she underwent pancreaticoduodenectomy. A Grade B bile leak complicated postoperative recovery, which was managed conservatively; she was discharged on postoperative day 28. Histology demonstrated a 20 × 17 mm IAPN confined to the ampullary bile duct without invasion of adjacent ducts, and immunophenotyping confirmed a gastric/pancreatobiliary phenotype. Incidentally, a separate 32 × 30 mm gallbladder fundus tumor was identified and diagnosed as primary gallbladder carcinoma invading only the muscular layer (pT1b, pN0). Resection margins were negative, and no adjuvant therapy was administered due to comorbid pulmonary disease. This case underscores the importance of thorough preoperative evaluation of the gallbladder in patients with ampullary neoplasms, even in the absence of known biliary tract anomalies. Recognition of synchronous malignancies may alter surgical planning and improve outcomes. Vigilant imaging, including targeted ultrasonography, should be incorporated into the preoperative workup for ampullary lesions to detect occult gallbladder carcinoma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.